Nachrichten zur Moderna Inc. Aktie

Moderna, Inc.: Moderna Reports Second Quarter 2023 Financial Results and Provides Business Updates

Second quarter 2023 revenues of $0.3 billion; net loss of $1.4 billion and loss per share of $3.62Company expecting 2023…

Moderna beats Q2 top and bottom line estimates; updates FY23 outlook

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Moderna, Inc. For: Aug 03

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Modernas Covid-19 Vaccine Demand Will Be Top of Mind on Earnings

While its Covid-19 vaccine became one of the best-selling medicines of all time, clocking $18.4 billion in sales in 2022,…

Moderna Reports Earnings Tomorrow. Covid-19 Vaccine Demand Will Be Top of Mind.

While its Covid-19 vaccine became one of the best-selling medicines of all time, clocking $18.4 billion in sales in 2022,…

Can Moderna spring a surprise for Q2 2023 despite falling vaccine demand

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Should You Buy Moderna (MRNA) Ahead of Earnings?

Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…

Moderna (MRNA) to Report Q2 Earnings: Will It Beat Estimates?

Investors focus will likely be on updates on Modernas (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter…

Subclinical Heart Damage More Prevalent Than Thought After Moderna Vaccination: Study

Subclinical Heart Damage More Prevalent Than Thought After Moderna Vaccination: Study …

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 1.806.229$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-07-26...…

Cathie Wood Is Buying Up Shares of This Beaten-Down Biotech. Should You?

Moderna shares have declined over the past year amid concerns about post-pandemic vaccine sales....…

UPDATE 3-Moderna/Merck begins late-stage study of skin cancer vaccine combination

...) July 26 (Reuters) - Moderna and its partner Merck said on Wednesday......…

CORRECTED-UPDATE 2-Moderna/Merck begins late-stage study of skin cancer vaccine combination

... and Merck) July 26 (Reuters) - Moderna said on Wednesday it has begun......…

Merck and Moderna launch late-stage trial of V940 with Keytruda as treatment for high-risk melanoma

Merck & Co. MRK and Moderna Inc. MRNA said Wednesday they have launched a Phase 3 trial of Moderna’s V940…

Merck, Moderna begin late-stage study of mRNA cancer vaccine

...(Reuters) - Merck, along with its partner Moderna, began a late......…

Moderna: Coverage aufgenommen

Chicago (www.aktiencheck.de) - Rating-Update: Myles Minter, Analyst von William Blair & Co, nimmt die Coverage der Aktie von Moderna Inc.…

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 1.882.151$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-07-19...…

Insiderhandel: President verkauft Aktien von MRNA im Wert von 1.809.000$

Hoge, Stephen - Vorstand - Tag der Transaktion: 2023-07-17...…

Moderna (MRNA) Stock Moves -0.32%: What You Should Know

Moderna (MRNA) closed at $124.77 in the latest trading session, marking a -0.32% move from the prior day....…

Insiderhandel: President verkauft Aktien von Moderna im Wert von 1.809.000$

Hoge, Stephen - Vorstand - Tag der Transaktion: 2023-07-17...…

Moderna Co-Founder Bought Up This Embattled Biotech Stock

Flagship Pioneering, an investment vehicle helmed by Noubar Afeyan, a co-founder of Moderna and its chairman, bought $12.5 million of…

HSBC bullish on Roche, Lonza; bearish on Bristol-Myers, GSK, Moderna

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 1.887.081$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-07-12...…

Biden administration asks Pfizer, Moderna and Novavax for reasonable prices on updated Covid vaccines

Pfizer, Moderna and Novavax have not disclosed the exact pricing of their new vaccines, which will target the circulating omicron…

Moderna, Inc.: Moderna to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023

CAMBRIDGE, MA / ACCESSWIRE / July 13, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…

Prime Day for Stocks? Disney, Moderna and 13 More That Look Like Bargains.

Amazon Prime shopping days are here, and everyone loves good deals, Barron's looked for some in the stock market, and…

Kooperationsvertrag: Moderna will mRNA-Medikamente in China entwickeln

Trotz politischer Spannungen zwischen den USA und China setzt der Impfstoffhersteller Moderna auf ein Engagement im Reich der Mitte. Das…

Insiderhandel: Aufsichtsrat verkauft Aktien von Moderna im Wert von 1.870.934$

Afeyan, Noubar - Aufsichtsrat - Tag der Transaktion: 2023-07-05...…

Moderna (MRNA) Initiates Rolling BLA Filing for RSV Vaccine

Alongside the FDA filing, Moderna (MRNA) submits similar filings in Europe and Australia, seeking approval for using its RSV vaccine…

Blitz-Update: Dow & Co starten mit Verlusten – Microsoft, Meta, Keurig Dr Pepper und Genius Sports stark, American Express, Affirm Holdings, Moderna und Lucid schwach

Die leichten Verluste der US-Börsen vom Vortag haben sich am Donnerstag ausgeweitet. Am Markt hieß es, Anleger machten sich angesichts…

A Big Test Is Looming for Pfizer, Moderna, and Novavax

Investors in these companies should brace for some potentially underwhelming results this year....…

Moderna signs deal with Shanghai to make mRNA vaccines for Chinese market

The Massachusetts-based company will work with local government to conduct clinical trials and apply to bring products to market as…

UPDATE 2-Moderna signs deal in Shanghai with view to developing mRNA medicines

... 3-4) SHANGHAI, July 5 (Reuters) - Vaccine maker Moderna Inc said... ... and will not be exported," a spokesperson told Reuters in…

Moderna To Develop mRNA Vaccines in China

The US and China may be taking jabs at one another over trade and other stuff, but that isnt stopping…

BRIEF-Shanghai Authorities Signed MoU With Moderna On Wednesday - Government Statement

...July 6 (Reuters) - Shanghai City Government: * SHANGHAI AUTHORITIES......…

Moderna (MRNA) Gains As Market Dips: What You Should Know

Moderna (MRNA) closed the most recent trading day at $123.54, moving +1.49% from the previous trading session....…

Dow & Co kaum verändert: Meta, Alphabet, Tesla, Moderna und Rivian top, Intel, Micron und UPS mit Verlusten – der Tag an der Wall Street

Die US-Aktienmärkte haben nach einer Feiertagspause am Mittwoch kaum auf die Bekanntgabe des Protokolls zur letzten US-Notenbanksitzung reagiert und letztlich…

Moderna: Hier steigt die Hoffnung auf lukrative Geschäfte mit China - Noch kein Befreiungsschlag - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Moderna Inc. (ISIN: US60770K1079,…

Moderna Strikes mRNA Drug Pact With Chinese Authorities: Report

Moderna Inc (NASDAQ: MRNA) reportedly struck a deal with Chinese authorities to research, develop, and manufacture messenger RNA (mRNA) medicines in…

Moderna: Deal mit China – auch BioNTech profitiert

Die Aktien der beiden Impfstoffhersteller Moderna und BioNTech können am heutigen Mittwoch deutlich zulegen. Moderna gewinnt 2,8 Prozent, BioNTech 2,5…

Blitz-Update: Dow & Co – Warten auf das Fed-Protokoll, Meta, Moderna, Rivian, Wolfspeed und Nvidia stark, Intel und Micron Technology schwach

Die US-Börsen haben nach einer Feiertagspause keine gemeinsame Richtung gefunden. Wenige Stunden vor Veröffentlichung des Protokolls zur letzten US-Notenbanksitzung taten…

Moderna Makes Regulatory Submissions for RSV Vaccine Candidate >MRNA

Moderna Makes Regulatory Submissions for RSV Vaccine Candidate >MRNA...…

Moderna stock pops after company makes regulatory submissions in U.S., Europe, Switzerland and Australia for its RSV vaccine

Moderna Inc.’s stock MRNA rose 3% Wednesday, after the company said it has made regulatory submissions in Europe, Switzerland and…

dpa-AFX ProFeed